Comparative Genome Analysis of Fusobacterium nucleatum Original paper
Researched by:
-
Divine Aleru
ID
Divine Aleru
Read MoreI am a biochemist with a deep curiosity for the human microbiome and how it shapes human health, and I enjoy making microbiome science more accessible through research and writing. With 2 years experience in microbiome research, I have curated microbiome studies, analyzed microbial signatures, and now focus on interventions as a Microbiome Signatures and Interventions Research Coordinator.
-
Microbes
Microbes
Microbes are microscopic organisms living in and on the human body, shaping health through digestion, vitamin production, and immune protection. When microbial balance is disrupted, disease can occur. This guide explains key microbe types—bacteria, viruses, fungi, protozoa, and archaea—plus major pathogenic and beneficial examples.
-
Divine Aleru
Read More
Researched by:
-
Divine Aleru
ID
Divine Aleru
Read More
Microbiome Signatures identifies and validates condition-specific microbiome shifts and interventions to accelerate clinical translation. Our multidisciplinary team supports clinicians, researchers, and innovators in turning microbiome science into actionable medicine.
Divine Aleru
What was studied?
This study performed a comparative genome analysis of Fusobacterium nucleatum, focusing specifically on the genome of F. nucleatum W1481. It aimed to evaluate the genomic differences between W1481 and other known F. nucleatum subspecies to investigate its potential as a novel subspecies. The study also examined the genomic content, including virulence factors, genomic islands, and pathogenic potential, through phylogenetic and pan-genome analysis.
Who was studied?
The study analyzed 21 genomes of Fusobacterium nucleatum strains, including W1481, isolated from various sources such as periodontal pockets and other strains from different subspecies (animalis, polymorphum, vincentii, fusiforme, and nucleatum). These strains were compared to assess genetic variations and the presence of unique genomic elements in W1481 that might suggest it is a new subspecies.
What were the most important findings?
The study found that Fusobacterium nucleatum W1481, originally isolated from a periodontal pocket in a patient with chronic periodontitis, is genetically distinct from the known subspecies of F. nucleatum. Phylogenetic analysis using 16S rRNA sequences and core-genome SNPs confirmed that W1481 clusters with F. nucleatum but does not align closely with any of the established subspecies, suggesting it could be a novel subspecies. The study also revealed the presence of several horizontally transferred genomic islands (GIs) unique to W1481, which may contribute to its virulence and survival strategies. These included genes for high-affinity transport systems, such as the TRAP-type C4-dicarboxylate transporters, which are involved in the uptake of malate, succinate, and fumarate. Additionally, W1481 exhibited unique features such as a CRISPR system, which may provide resistance to foreign DNA, and genes for the catabolism of lactate and succinate. The presence of efflux pumps and beta-lactamase-related proteins suggests that W1481 might be resistant to certain antibiotics, contributing to its persistence in clinical settings.
What are the greatest implications of this study?
The identification of Fusobacterium nucleatum W1481 as a potential new subspecies opens the door for deeper exploration into its unique virulence factors and its role in periodontal disease and other infections. The study’s findings suggest that the horizontal gene transfer observed in W1481, particularly genes related to nutrient transport and immune evasion, could provide new insights into the bacterium’s adaptability and pathogenicity. Understanding these unique genomic elements could lead to the development of targeted treatments that address the specific survival mechanisms of W1481 and other F. nucleatum strains. Additionally, the discovery of antibiotic resistance mechanisms, including beta-lactamase production, highlights the need for careful consideration in treatment strategies involving F. nucleatum-related infections.
Fusobacterium nucleatum
Fusobacterium nucleatum is a Gram-negative, anaerobic bacterium commonly found in the oral cavity, where it plays a crucial role in the formation of biofilms. Beyond its presence in the mouth, Fn is implicated in a variety of systemic conditions, including periodontal disease, colorectal cancer, and inflammatory bowel disease. Known for its ability to coaggregate with other bacteria, Fn's pathogenic potential is magnified in dysbiotic microbial communities, making it a key player in polymicrobial infections. The bacterium utilizes multiple virulence factors such as FadA and Fap2, which facilitate adhesion to host tissues and immune evasion, ultimately contributing to its role in chronic and inflammatory diseases.